Medicare Enrolled

Dr. Scott Levenson, MD

Gastroenterology · San Carlos, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
1000 LAUREL ST, San Carlos, CA 94070
6505968800
In practice since 2005 (20 years)
NPI: 1578548186 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Levenson from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Levenson? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Levenson

Dr. Scott Levenson is a gastroenterology specialist in San Carlos, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Levenson performed 1,602 Medicare services across 1,365 unique beneficiaries.

Between the years covered by Open Payments, Dr. Levenson received a total of $120,063 from 51 pharmaceutical and/or device companies across 1443 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Levenson is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 15% volume in CA $120,063 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,602
Medicare services
Top 15% in CA for gastroenterology
1,365
Unique beneficiaries
$112
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~80 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
303 $112 $186
Moderate sedation during GI endoscopy
Sedation services provided by the physician performing a gastrointestinal endoscopic procedure. This requires an independent trained observer to assist in monitoring the patient.
299 $4 $300
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
152 $155 $226
Upper GI endoscopy with biopsy
A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities.
120 $96 $749
Colon polyp removal with endoscopic snare
This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination.
91 $239 $949
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
90 $126 $301
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
88 $80 $188
External hemorrhoid removal by rubber banding
A procedure to remove external hemorrhoids using rubber bands to cut off blood supply. The affected tissue is tied off and eventually falls off.
70 $186 $500
New patient office visit, complex (60-74 min) 68 $193 $367
Colonoscopy for colorectal cancer screening, high risk
A colonoscopy performed to screen for colorectal cancer in individuals identified as being at high risk for the disease.
63 $204 $899
Colonoscopy with biopsy
A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease.
62 $88 $949
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
58 $108 $228
Colonoscopy for colorectal cancer screening
A colonoscopy performed to screen for colorectal cancer in individuals who are not at high risk for the disease.
35 $205 $899
Colonoscopy
A diagnostic exam of the large bowel using a flexible endoscope to visualize the interior of the colon.
27 $163 $899
Anoscopy
A diagnostic exam of the anus using a thin, lighted tube called an endoscope to look inside.
23 $114 $145
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
20 $29 $40
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
18 $157 $375
Online digital evaluation for established patient, 5-10 minutes
This service involves an online digital evaluation and management visit for an established patient. It covers a total time of 5 to 10 minutes over a period of up to 7 days.
15 $14 $45
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$120,063
Total received (2018-2024)
Avg $17,152/year across 7 years
Top 4% in CA for gastroenterology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
51
Companies
1,443
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$99,731 (83.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,485 (12.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$5,847 (4.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$56,775
2023
$16,383
2022
$5,167
2021
$10,375
2020
$13,979
2019
$10,753
2018
$6,631

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Phathom Pharmaceuticals, Inc.
$41,232
ABBVIE INC.
$8,395
AIMMUNE THERAPEUTICS, INC.
$2,737
QOL Medical, LLC
$2,383
Janssen Biotech, Inc.
$400
Gilead Sciences, Inc.
$251
Lilly USA, LLC
$234
Takeda Pharmaceuticals U.S.A., Inc.
$209
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$204
Madrigal Pharmaceuticals
$156
Celltrion USA Inc.
$123
Merck Sharp & Dohme LLC
$73
IRONWOOD PHARMACEUTICALS, INC
$58
VIVUS LLC
$49
Celgene Corporation
$45
Intercept Pharmaceuticals, Inc.
$40
GENZYME CORPORATION
$39
Janssen Scientific Affairs, LLC
$35
Echosens North America, Inc.
$31
Exact Sciences Corporation
$27
Ipsen Biopharmaceuticals, Inc
$22
Braintree Laboratories, Inc.
$19
Ferring Pharmaceuticals Inc.
$15
Top 3 companies account for 92.2% of 2024 payments
All-time payments by company (2018-2024) ›
Phathom Pharmaceuticals, Inc.
$41,232
AbbVie Inc.
$15,380
ABBVIE INC.
$15,248
Allergan Inc.
$6,864
QOL Medical, LLC
$6,023
NESTLE HEALTHCARE NUTRITION INC.
$5,797
AbbVie, Inc.
$4,729
Janssen Biotech, Inc.
$2,882
AIMMUNE THERAPEUTICS, INC.
$2,737
Takeda Pharmaceuticals U.S.A., Inc.
$2,466
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$2,376
RedHill Biopharma Inc.
$2,069
E.R. Squibb & Sons, L.L.C.
$1,975
Gilead Sciences, Inc.
$1,676
Ironwood Pharmaceuticals, Inc
$1,401
Allergan, Inc.
$963
Stryker Corporation
$600
Daiichi Sankyo Inc.
$568
Janssen Scientific Affairs, LLC
$479
Braintree Laboratories, Inc.
$357
Ardelyx, Inc.
$356
Nestle HealthCare Nutrition Inc.
$328
Ferring Pharmaceuticals Inc.
$286
Romark Laboratories, LC
$281
Shire North American Group Inc
$269
Celgene Corporation
$264
Lilly USA, LLC
$256
Merck Sharp & Dohme LLC
$245
IRONWOOD PHARMACEUTICALS, INC
$245
Intercept Pharmaceuticals, Inc.
$237
Synergy Pharmaceuticals Inc
$171
Madrigal Pharmaceuticals
$156
Celltrion USA Inc.
$148
VIVUS LLC
$140
Merck Sharp & Dohme Corporation
$103
GENZYME CORPORATION
$103
Endo Pharmaceuticals Inc.
$99
Regeneron Healthcare Solutions, Inc.
$75
INTERCEPT PHARMACEUTICALS, INC.
$64
PFIZER INC.
$58
Echosens North America, Inc.
$56
Amgen Inc.
$53
AstraZeneca Pharmaceuticals LP
$53
Prometheus Laboratories Inc.
$47
Exact Sciences Corporation
$27
Biocompatibles, Inc.
$24
Sandoz Inc.
$23
Ipsen Biopharmaceuticals, Inc
$22
VIVUS, Inc.
$21
Digestive Care, Inc.
$20
Shionogi Inc
$14
Top 3 companies account for 59.9% of all-time payments
Associated products mentioned in payments ›
ALINIA · AMJEVITA · APRISO · AVSOLA · Aemcolo · Alinia · Alinia Tablets 500mg 30 count bottle · Amitiza · Bylvay · CIMZIA · CLENPIQ · CREON · Cologuard Collection Kit · Creon · DIFICID · DUPIXENT · Dexilant · ENTYVIO · EOHILIA · Entyvio · FibroScan · Fibroscan · GATTEX · HUMIRA · HYRIMOZ · Humira · IBSRELA · INJECTAFER · LINZESS · Linzess · MAVYRET · MOTEGRITY · MOVANTIK · MOVIPREP · Mavyret · Motegrity · Movantik · NASCOBAL · NEW PRODUCT DEVELOPMENT · OCALIVA · OMVOH · PANCREAZE · PLENVU · Pancreaze · Pertzye · REBYOTA · RELISTOR · REMICADE · RESMETIROM · RINVOQ · SKYRIZI · STELARA · SUCRAID · SUFLAVE · SUPREP · SUPREP BOWEL PREP · SUTAB · Sucraid · Symproic · TALICIA · THERASPHERE - BIO · TREMFYA · TRULANCE · Talicia · Trintellix · Trulance · UCERIS · VEGZELMA · VIBERZI · VOQUEZNA · VOWST · VRAYLAR · Vemlidy · XELJANZ · XIFAXAN · YUFLYMA · ZENPEP · ZEPOSIA · ZYMFENTRA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (83%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in gastroenterology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 4% for gastroenterology in CA.

Looking for a gastroenterology specialist in San Carlos?
Compare gastroenterologists in the San Carlos area by procedure volume, costs, and industry payment transparency.
Browse gastroenterologists nearby

Geographic Context

Gastroenterologists within 10 mi
238
Per 100K population
31.9
County median income
$156,000
Nearest hospital
SAN MATEO MEDICAL CENTER
3.4 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Levenson is a clinical cardiology specialist, with above-average Medicare volume (top 15% in CA), with speaking/promotional industry engagement in the top 4% of CA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Levenson experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Levenson performed 303 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Levenson receive payments from pharmaceutical companies?
Yes. Dr. Levenson received a total of $120,063 from 51 companies across 1,443 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Levenson's costs compare to other gastroenterologists in San Carlos?
Dr. Levenson's average Medicare payment per service is $112. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Levenson) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →